Multifunctional Tumor Suppressor

Slides:



Advertisements
Similar presentations
ZAFIA ANKLESARIA Role of BMPR1A in Juvenile Polyposis Syndrome Biology 169.
Advertisements

LKB1 and Peutz-Jeghers Syndrome Josh Lawrimore. Gene Specifics.
Phosphatase and Tensin Homolog Deleted on Chromosome 10
BRCA Mutations and Breast Cancer Ruth Phillips and Patty Ashby.
Malignant Melanoma and CDKN2A
. Cell Division- Regulation of the Cell Cycle. Target #25-I can explain the external factors that are involved in cell cycle regulation Both external.
P53 Missense Mutation Cancer. Outline Disease related to p53 Role and regulation pathway Structure of p53 Missense mutation and consequences Experiment’s.
Essentials of Biology Sylvia S. Mader
BMPR1A Bone Morphogenetic Protein Receptor 1 A (Juvenile Polyposis & Colon Cancer) Hallie Wieters.
The Cell Cycle and Cancer AP Biology. Cell Cycle Numerous genes control the cell cycle They regulate the progression through checkpoints. A sensor detects.
TSC1 and Facial Angiofibromas
PTEN and its Role in Cowden Syndrome and Sporadic Cancers John Cuningham Biology 445.
TSC1/Hamartin and Facial Angiofibromas Biology 169 Ann Hau.
PTEN (Cowden Syndrome) /.../ sld083.htm.
PTEN (Phosphatase and Tensin Homolog) a.k.a. MMAC1, TEP1 Raymond Stadiem.
Cowden’s Disease and PTEN. Cowden’s Disease (CD)  A rare autosomal dominant disease similar to Lehrmitte-Duclos Disease (LDD) and Bannayan-Zonana Syndrome.
P57(KIP2) and Beckwith-Wiedemann Syndrome Shannon O’Leary.
Cell Growth & Division Control of Cell Cycle | Disruptions to Cell Cycle.
Cell Signaling Pathways – A Case Study Approach
Julie Grondin March 10th, 2005 Bio 169
STAT3 Michael Patel.
Peutz-Jeghers Syndrome and LKB1/STK11
What makes a mutant?.
Bone Morphogenetic Protein Receptor 1A (BMPR1A) and Juvenile Polyposis Syndrome Cara Davidson March 18, 2004.
Small Cell Lung Cancer Exhibits Frequent Inactivating Mutations in the Histone Methyltransferase KMT2D/MLL2: CALGB (Alliance)  Arnaud Augert, PhD,
Tuberous Sclerosis TSC2/ Tuberin Alison Chappell.
Concept 18.5: Cancer results from genetic changes that affect cell cycle control The gene regulation systems that go wrong during cancer are the very same.
Chap. 16 Problem 1 Cytokine receptors and RTKs both form functional dimers on binding of ligand. Ligand binding activates cytosolic kinase domains which.
Genetics of Cancer.
The promise of cancer genetics
PTEN (a.k.a. MMAC1 and TEP1) and Cowden’s Disease
Graduate School of Medical Science & Egineering
Dan Gordon  Gastroenterology  Volume 114, Issue 4, (April 1998)
Extracellular Regulation of Apoptosis
Figure 1 A schematic representation of the HER2 signalling pathway
Volume 150, Issue 3, Pages (September 2018)
Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3- Kinase/AKT/Mammalian Target of Rapamycin Pathway  Gozde Akgumus, Fengqi.
PTEN Tumor Suppressor Extraordinaire
Nat. Rev. Urol. doi: /nrurol
In-vitro regulation of primordial follicle activation: challenges for fertility preservation strategies  Michael J. Bertoldo, Kirsty A. Walters, William.
PTEN Tumor Suppressor and Cancer
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
Jing Zhang, Thomas M. Roberts, Ramesh A. Shivdasani  Gastroenterology 
Maria M. Mihaylova, David M. Sabatini, Ömer H. Yilmaz  Cell Stem Cell 
EGFR T790M Mutation: A Double Role in Lung Cancer Cell Survival?
The promise of cancer genetics
Ataxia telangiectasia and the Role of ATM
Figure 24.1 Phases of the cell cycle.
BMP Receptor 1a and Juvenile Polyposis Syndrome
PKB Binding Proteins Cell
Janus Kinase Deregulation in Leukemia and Lymphoma
Figure 1 The insulin signalling pathway
p27 as a target for cancer therapeutics
Deregulation of p27 and Cyclin D1/D3 Control Over Mitosis Is Associated with Unfavorable Prognosis in Non-small Cell Lung Cancer, as Determined in 405.
Temperature-Sensitive RB Mutations Linked to Incomplete Penetrance of Familial Retinoblastoma in 12 Families  Gregory A. Otterson, Sanjay Modi, Kari Nguyen,
RAS Proteins and Their Regulators in Human Disease
AKT/PKB Signaling: Navigating Downstream
Signalling links in the liver: Knitting SOCS with fat and inflammation
Crystal Structure of a Phosphoinositide Phosphatase, MTMR2
Germline PIK3CA and AKT1 Mutations in Cowden and Cowden-like Syndromes
Simon Ekman, MD, PhD, Murry W. Wynes, PhD, Fred R. Hirsch, MD, PhD 
Dysregulation of the mTOR Pathway Secondary to Mutations or a Hostile Microenvironment Contributes to Cancer and Poor Wound Healing  Richard A.F. Clark,
Guilty as charged Cancer Cell
Volume 7, Issue 1, Pages 1-11 (July 1997)
Interactions of the Auxilin-1 PTEN-like Domain with Model Membranes Result in Nanoclustering of Phosphatidyl Inositol Phosphates  Antreas C. Kalli, Gareth.
Brief Review – Growth Factors and Receptors
Tenets of PTEN Tumor Suppression
Successful targeting of ErbB2 receptors—is PTEN the key?
PTEN and p53: Who will get the upper hand?
Presentation transcript:

Multifunctional Tumor Suppressor PTEN Multifunctional Tumor Suppressor

PTEN crystal structure contains a phosphatase and C2 domain Figure 1. Structure of PTEN. (A) Domain structure of PTEN. (B) The crystal structure of PTEN, with the phosphatase domain (PD; residues 14–185) in pink and the C2 domain (residues 186–351) in cyan. The tartrate molecule bound in the phosphatase active site is shown as van der Waals spheres. The loop missing from the crystal structure between P281 and K313 is shown as a dotted line. (C) Coarse-grained (CG) representation of PTEN. The bound tartrate has been replaced with a CG representation of PI(3,4,5)P3, with the PI(3,4,5)P3 molecule positioned as described in the main text. PTEN Crystal Structure http://www.sciencedirect.com/science/article/pii/S0006349512050801 Missense- residue is where it is: WT vs. Mutant (find it in Cowden’s syndrome) most prevalent one Lumb, C. N., & Sansom, M. S. (2013). Defining the Membrane-Associated State of the PTEN Tumor Suppressor Protein. Biophysical Journal, 104(3), 613-621.

PTEN binds PIP3, a phospholipid substrate = Lumb, C. N., & Sansom, M. S. (2013). Defining the Membrane-Associated State of the PTEN Tumor Suppressor Protein. Biophysical Journal, 104(3), 613-621.

PTEN opposes PI3 Kinase to keep PIP3 levels low PTEN and phosphorylated Akt levels were inversely correlated in the large majority of examined samples, suggesting that PTEN regulates phosphatidylinositol 3,4,5-triphosphates and may play a role in apoptosis.  The studies suggested that the PTEN tumor suppressor modulates G1 cell cycle progression through negatively regulating the PI3K (see 171834)/Akt (164730) signaling pathway, and that 1 critical target of this signaling process is the cyclin-dependent kinase inhibitor p27(KIP1) (600778). J. Clin Oncol. July 15, 2004 vol. 22 no. 14 2954-2963. DOI: 10.1200/JCO.2004.02.141

PTEN regulates the AKT pathway which has multiple biological roles Backman, S., Stambolic, V., & Mak, T. (2002). PTEN function in mammalian cell size regulation. Current opinion in neurobiology, 12(5), 516.

Mice PTEN null ES cells grow excessively with disorganized patterning Embryonic lethal Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998). Pten is essential for embryonic development and tumour suppression. Nature genetics, 19(4), 348-355.

Cancers with PTEN mutations occur in a dosage dependent manner Cristofano, A. D., Pesce, B., Cordon-Cardo, C., & Pandolfi, P. P. (1998). Pten is essential for embryonic development and tumour suppression. Nature genetics, 19(4), 348-355. http://www.nature.com/ng/journal/v42/n5/images_article/ng.556-F3.jpg

PTEN is one of the most frequently mutated genes in human cancers Eng, C. (2003). PTEN: one gene, many syndromes. Human mutation, 22(3), 183-198.

Cowden Syndrome : hamartomas, benign tumors due to germline mutations often in PTEN phosphatase catalytic site http://www.hinsdale86.org/staff/kgabric/Disease10/Cowden%20Syndrome/Index1.htm Loss-of-function phosphatase and tensin homologue (PTEN) mutations predispose not only to Cowden syndrome (CS), but also to a group of seemingly clinically disparate disorders that, with CS, are collectively referred to as the PTEN hamartoma tumour syndromes (PHTS). About two-thirds of PTEN mutations in CS are found in exons 5, 7,and 8, with 40% in exon 5, although this exon represents only 20% of the coding sequence. This region encodes the crucial phosphatase core motif. Missense mutations within the phosphatase core motif and missense or nonsense mutations 5' of it seem to be associated with the involvement of five or more organs, suggesting a correlation between mutations in this region of PTEN and disease severity65. Germline PTEN loss LOH Phosphatase domain Insulin in context of growth http://www.hinsdale86.org/staff/kgabric/Disease10/Cowden%20Syndrome/Index1.htm

Cowden Syndrome patients display an increased predisposition for cancer More common in females or males?